1. Fractional‐Pixel CO 2 Laser Treatment in Patients With Urodynamic Stress Urinary Incontinence: 1‐Year Follow‐Up
- Author
-
M. Alcalay, Moshe Ben Ami, Eyal Schiff, Zion Hagay, and Anatoly Greenshpun
- Subjects
medicine.medical_specialty ,Stress incontinence ,Co2 laser ,Pelvic floor ,business.industry ,Urinary system ,Urinary incontinence ,Dermatology ,medicine.disease ,01 natural sciences ,Surgery ,010309 optics ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Distress ,0302 clinical medicine ,medicine.anatomical_structure ,Quality of life ,0103 physical sciences ,medicine ,medicine.symptom ,Adverse effect ,business - Abstract
BACKGROUND AND OBJECTIVES Vaginal pixelated low power and long pulses (LPLP) CO2 laser has been suggested as an optional treatment for stress urinary incontinence (SUI) with many studies reporting short-term improvements. The objective of this study was to assess the 1-year subjective and objective efficacy of vaginal CO2 laser in women with urodynamic SUI. STUDY DESIGN/MATERIALS AND METHODS This was a prospective multicenter study. Patients with confirmed urodynamic SUI graded as mild or moderate were included. We used three sessions of fractional pixelated CO2 laser for vaginal application and followed up the patients at 6 and 12 months. We used the following measures at follow-up: 1-hour pad test (ICS protocol), questionnaires including Pelvic Floor Distress Inventory 20 (PFDI-20), Pelvic Floor Impact Questionnaire (PFIQ), Patient Global Impression of Improvement (PGI-I), and a 3-day urinary diary. The urodynamic assessment was repeated at 6 months. RESULTS Fifty-two patients with SUI had three laser treatments, of whom 48 completed a 6-month follow-up and 42 patients completed 12-month follow-up. No serious adverse events were recorded during the study period. A significant reduction on the 1-hour pad test was found from baseline (6.3 ± 1.6 g) to the 12-month follow-up (3.7 ± 1.4 g, P
- Published
- 2020